Skip to search formSkip to main contentSkip to account menu

Neoantigen-based Melanoma-Poly-ICLC Vaccine

Known as: NeoVax Melanoma Vaccine 
A peptide-based melanoma cancer vaccine consisting of neoantigens and peptides derived from patient-specific melanoma immunogenic epitopes, combined… 
National Institutes of Health

Related topics

Related topics

1 relation
NCIt Antineoplastic Agent Terminology

Search for papers about Neoantigen-based Melanoma-Poly-ICLC Vaccine

Search papers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)